ZA97444B - Potentiating agents. - Google Patents

Potentiating agents.

Info

Publication number
ZA97444B
ZA97444B ZA9700444A ZA97444A ZA97444B ZA 97444 B ZA97444 B ZA 97444B ZA 9700444 A ZA9700444 A ZA 9700444A ZA 97444 A ZA97444 A ZA 97444A ZA 97444 B ZA97444 B ZA 97444B
Authority
ZA
South Africa
Prior art keywords
carbamate
benzyl
propyl
steroid
oconr1r2
Prior art date
Application number
ZA9700444A
Other languages
English (en)
Inventor
Satish Batra
Jan-Inge Carlsson
Thomas Fex
Original Assignee
Satish Batra
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Satish Batra filed Critical Satish Batra
Publication of ZA97444B publication Critical patent/ZA97444B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ZA9700444A 1996-01-23 1997-01-20 Potentiating agents. ZA97444B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9600229A SE9600229D0 (sv) 1996-01-23 1996-01-23 Novel potentiating agents

Publications (1)

Publication Number Publication Date
ZA97444B true ZA97444B (en) 1997-09-03

Family

ID=20401110

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9700444A ZA97444B (en) 1996-01-23 1997-01-20 Potentiating agents.

Country Status (9)

Country Link
US (1) US6046182A (fr)
EP (1) EP0885239B1 (fr)
JP (1) JP2000503985A (fr)
AT (1) ATE221896T1 (fr)
AU (1) AU728258B2 (fr)
DE (1) DE69714577T2 (fr)
SE (1) SE9600229D0 (fr)
WO (1) WO1997027211A1 (fr)
ZA (1) ZA97444B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL133809A0 (en) * 1999-12-30 2001-04-30 Yeda Res & Dev Steroidal alkaloids and pharmaceutical compositions comprising them
US20070281040A1 (en) * 2004-09-30 2007-12-06 The University Of Chicago Combination therapy of hedgehog inhibitors, radiation and chemotherapeutic agents
KR20200022525A (ko) 2008-12-04 2020-03-03 충시 위 고투과력을 가진 조성물 및 이의 적용
EP2512485A1 (fr) * 2009-12-18 2012-10-24 Institut National de la Santé et de la Recherche Médicale (INSERM) Nouveaux inhibiteurs stéroïdiens de pgp pour emploi dans l'inhibition de la résistance pléiotrope
EP2542085A4 (fr) * 2010-03-03 2013-12-04 Satori Pharmaceuticals Inc Composés utiles pour le traitement de troubles neurodégénératifs
US20130060013A1 (en) * 2011-09-07 2013-03-07 Satori Pharmaceuticals, Inc. Compounds useful for treating neurodegenerative disorders
EP3275888B1 (fr) * 2016-07-28 2019-09-25 Council of Scientific & Industrial Research Hybride de lipide progestérone-cationique en tant qu'agent anticancéreux et son procédé de synthèse

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3787453A (en) * 1971-10-26 1974-01-22 Hoffmann La Roche Steroid carbamates
DE3769676D1 (de) * 1986-03-14 1991-06-06 Fujisawa Pharmaceutical Co Prodrugverbindungen, verfahren zu deren herstellung und diese enthaltende zubereitungen mit verzoegerter freisetzung.
US5294536A (en) * 1992-04-23 1994-03-15 Pb Diagnostic Systems, Inc. Conjugates

Also Published As

Publication number Publication date
US6046182A (en) 2000-04-04
EP0885239A1 (fr) 1998-12-23
AU728258B2 (en) 2001-01-04
ATE221896T1 (de) 2002-08-15
AU1565097A (en) 1997-08-20
SE9600229D0 (sv) 1996-01-23
JP2000503985A (ja) 2000-04-04
WO1997027211A1 (fr) 1997-07-31
DE69714577T2 (de) 2003-04-10
EP0885239B1 (fr) 2002-08-07
DE69714577D1 (de) 2002-09-12

Similar Documents

Publication Publication Date Title
NO942953L (no) 11-benzaldoksimestradienderivater, fremgangsmåte for deres fremstilling smat legemddel inneholdende slike
CA2216796A1 (fr) Derives de quinazoline
NO963053D0 (no) Kosmetiske eller farmasöytiske preparater inneholdende mangiferin eller derivater derav
GB2334521A (en) Anthranilic acid derivatives as multi drug resistance modulators
NO970068D0 (no) Inhaleringssammensetning
CA2209001A1 (fr) Derives hydrophobes du taxane
HU229443B1 (en) Betha-carboline particulate form, pharmaceutical compositions containing it, their preparations and their use
TR199900336T2 (xx) EAA antagonistleri olarak tetrahidrokinolin t�revleri.
CA2306782A1 (fr) Isoquinolines comme inhibiteurs de l'urokinase
ZA97444B (en) Potentiating agents.
AU3636089A (en) Hydrazine derivatives for pharmaceutical use
ATE268174T1 (de) Sibutramin und orlistat enthaltende pharmazeutische zusammensetzungen
ATE14222T1 (de) Sekundaere aethanolamine, ihre herstellung und ihre verwendung in pharmazeutischen zusammensetzungen.
UA42733C2 (uk) Похідні біснафталіміду та їх фармацевтично прийнятні кислотно-адитивні солі, фармацевтична композиція з цитотоксичною активністю, яка їх містить
ES2062137T3 (es) Utilizacion de 5'-deoxi-5'-metil-tioadenosina, s-adenosilmetionina y sus sales para la preparacion de composiciones farmaceuticas reductoras de seborrea.
PL307333A1 (en) Improved antiandrogens
UA41880C2 (uk) Серотонінергічні похідні ерголіну і фармацевтична композиція
CA2244001A1 (fr) Nouveaux carbamates de steroides en tant qu'agents de potentialisation
ATE296115T1 (de) Ortsspezifische arzneimittel verabreichung
CA2112690A1 (fr) Derive d'un acide amine
NO950177D0 (no) Farmakologisk aktive erivater
RU95106652A (ru) Оптически активные производные карбоксамида, аналгезирующее средство
HUP0301334A2 (hu) Szubsztituált akriloil-disztamicin-származékokat és taxánokat és/vagy antimetabolitokat tartalmazó kombinált tumorellenes kompozíciók
TW337521B (en) Non-ulcerogenic analgesic/anti-inflammatory cloixin derivative
WO1995006473A3 (fr) Utilisation medicale d'un compose d'acide polysulfonique